stockrowBurning Rock Biotech Limited Sponsored ADR (BNR) vs Insight Molecular Diagnostics Inc. (IMDX)
- Burning Rock Biotech Limited Sponsored ADR BNR 13.20 −0.38%
- Insight Molecular Diagnostics Inc. IMDX 2.51 +2.03%
Burning Rock Biotech Limited Sponsored ADR and Insight Molecular Diagnostics Inc. are both Diagnostics & Research companies. Burning Rock Biotech Limited Sponsored ADR is the larger, with a market value of $116.5M against $80.5M — 1.4× the size. Burning Rock Biotech Limited Sponsored ADR grew revenue faster over the last twelve months: −0.14% against −60.8%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −2,955.6%) and the lower return on invested capital (−50.7% vs 0.00%). Across the 17 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 12 and Insight Molecular Diagnostics Inc. on 5.
Valuation
Profitability
| Metric | BNR | IMDX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.50% | 48.32% | 48.32% |
| Operating margin | (12.95%) | (3,011.86%) | (5.68%) |
| Net margin | (13.51%) | (2,955.63%) | (4.10%) |
| Free cash flow margin | (3.00%) | (1,856.23%) | 0.00% |
| Return on equity | (13.08%) | 488.68% | 0.00% |
| Return on assets | (8.81%) | (123.46%) | (6.05%) |
| Return on invested capital | (50.66%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack